283 related articles for article (PubMed ID: 18298856)
1. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.
Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Pibiri M; Nair SV; Walker JM; Pennell DJ
J Cardiovasc Magn Reson; 2008 Feb; 10(1):12. PubMed ID: 18298856
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.
Pennell DJ; Berdoukas V; Karagiorga M; Ladis V; Piga A; Aessopos A; Gotsis ED; Tanner MA; Smith GC; Westwood MA; Wonke B; Galanello R
Blood; 2006 May; 107(9):3738-44. PubMed ID: 16352815
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.
Pepe A; Meloni A; Rossi G; Cuccia L; D'Ascola GD; Santodirocco M; Cianciulli P; Caruso V; Romeo MA; Filosa A; Pitrolo L; Putti MC; Peluso A; Campisi S; Missere M; Midiri M; Gulino L; Positano V; Lombardi M; Ricchi P
J Cardiovasc Magn Reson; 2013 Jan; 15(1):1. PubMed ID: 23324167
[TBL] [Abstract][Full Text] [Related]
5. Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.
Kolnagou A; Kontoghiorghes GJ
Hemoglobin; 2006; 30(2):239-49. PubMed ID: 16798649
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major.
Alpendurada F; Smith GC; Carpenter JP; Nair SV; Tanner MA; Banya W; Dessi C; Galanello R; Walker JM; Pennell DJ
J Cardiovasc Magn Reson; 2012 Jan; 14(1):8. PubMed ID: 22277065
[TBL] [Abstract][Full Text] [Related]
7. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.
Cassinerio E; Roghi A; Pedrotti P; Brevi F; Zanaboni L; Graziadei G; Pattoneri P; Milazzo A; Cappellini MD
Ann Hematol; 2012 Sep; 91(9):1443-9. PubMed ID: 22572843
[TBL] [Abstract][Full Text] [Related]
8. Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.
Smith GC; Alpendurada F; Carpenter JP; Alam MH; Berdoukas V; Karagiorga M; Ladis V; Piga A; Aessopos A; Gotsis ED; Tanner MA; Westwood MA; Galanello R; Roughton M; Pennell DJ
J Cardiovasc Magn Reson; 2011 Jul; 13(1):34. PubMed ID: 21733147
[TBL] [Abstract][Full Text] [Related]
9. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.
Tanner MA; Galanello R; Dessi C; Westwood MA; Smith GC; Nair SV; Anderson LJ; Walker JM; Pennell DJ
J Cardiovasc Magn Reson; 2006; 8(3):543-7. PubMed ID: 16755844
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.
Tsironi M; Assimakopoulos G; Polonofi K; Rigaki K; Aessopos A
Hemoglobin; 2008; 32(1-2):29-34. PubMed ID: 18274980
[TBL] [Abstract][Full Text] [Related]
11. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
Taher A; Sheikh-Taha M; Koussa S; Inati A; Neeman R; Mourad F
Eur J Haematol; 2001 Jul; 67(1):30-4. PubMed ID: 11553264
[TBL] [Abstract][Full Text] [Related]
12. Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine.
Elalfy MS; Abdin IA; El Safy UR; Ibrahim AS; Ebeid FS; Salem DS
Hematol Oncol Stem Cell Ther; 2010; 3(4):174-8. PubMed ID: 21150236
[TBL] [Abstract][Full Text] [Related]
13. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone.
Porter JB; Wood J; Olivieri N; Vichinsky EP; Taher A; Neufeld E; Giardina P; Thompson A; Moore B; Evans P; Kim HY; Macklin EA; Trachtenberg F
J Cardiovasc Magn Reson; 2013 May; 15(1):38. PubMed ID: 23688265
[TBL] [Abstract][Full Text] [Related]
14. comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major.
Perifanis V; Christoforidis A; Vlachaki E; Tsatra I; Spanos G; Athanassiou-Metaxa M
Int J Hematol; 2007 Dec; 86(5):385-9. PubMed ID: 18192103
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study.
Berdoukas V; Chouliaras G; Moraitis P; Zannikos K; Berdoussi E; Ladis V
J Cardiovasc Magn Reson; 2009 Jun; 11(1):20. PubMed ID: 19558722
[TBL] [Abstract][Full Text] [Related]
16. Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
Saliba AN; El Rassi F; Taher AT
Expert Rev Hematol; 2016; 9(2):151-68. PubMed ID: 26613264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.
Anderson LJ; Wonke B; Prescott E; Holden S; Walker JM; Pennell DJ
Lancet; 2002 Aug; 360(9332):516-20. PubMed ID: 12241655
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined chelation therapy with deferiprone and deferoxamine on left ventricular diastolic function in adult beta-thalassemia major patients.
Tsiapras D; Fragatou S; Farmaki K; Kyrzopoulos S; Paraskevaidis I; Voudris V; Kremastinos D
Hemoglobin; 2010 Jun; 34(3):210-20. PubMed ID: 20524811
[TBL] [Abstract][Full Text] [Related]
19. Oral deferiprone for iron chelation in people with thalassaemia.
Fisher SA; Brunskill SJ; Doree C; Chowdhury O; Gooding S; Roberts DJ
Cochrane Database Syst Rev; 2013 Aug; (8):CD004839. PubMed ID: 23966105
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
